|
|
Volumn 55, Issue 7, 2011, Pages 3631-3634
|
|
JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CIPROFLOXACIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
DAPTOMYCIN;
ERYTHROMYCIN;
JNJ Q 2;
LEVOFLOXACIN;
LINEZOLID;
MOXIFLOXACIN;
OXACILLIN;
PENICILLIN G;
QUINOLONE DERIVATIVE;
TETRACYCLINE;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL SKIN DISEASE;
BACTERIUM ISOLATION;
CONTROLLED STUDY;
IC 50;
IN VITRO STUDY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
SKIN STRUCTURE;
STAPHYLOCOCCUS AUREUS;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
AZA COMPOUNDS;
CIPROFLOXACIN;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
FLUOROQUINOLONES;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIAL SENSITIVITY TESTS;
OFLOXACIN;
QUINOLINES;
STAPHYLOCOCCUS AUREUS;
|
|
EID: 79959277680
PISSN: 00664804
EISSN: 10986596
Source Type: Journal
DOI: 10.1128/AAC.00162-11 Document Type: Article |
|
Times cited : (24)
|
|
References (7)
|
